Cite
HARVARD Citation
Dhere, T. et al. (2016). The safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn's disease – a phase 1 trial with three doses. Alimentary pharmacology & therapeutics. 44 (5), pp. 471-481. [Online].